BRAIDWELL LP

Position in EOLS — Evolus, Inc.

CIK 1920938 STAMFORD, CT

Position in EOLS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$21,897,150

+$9,134,742 QoQ

Shares Held

3,155,209

+1.6% QoQ

Ownership

4.78%

of shares outstanding

% of Portfolio

0.84%

of 13F equity value

Holder Rank

of 158 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BRAIDWELL LP holds $115,632,817 across 4 Drug Manufacturers - Specialty & Generic names. EOLS ranks #3 (18.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	336,171	$56,658,260
2	BIOA	BioAge Labs, Inc.	1,033,129	$25,321,991
3	EOLS	Evolus, Inc. This page	3,155,209	$21,897,150
4	KNSA	Kiniksa Pharmaceuticals International, plc	183,822	$11,755,416

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$21,897,150	3,155,209	+1.6%	Shares	Sole	2026-08-14
2026-03-31	$12,762,408	3,105,209	0.0%	Shares	Sole	2026-05-15
2025-12-31	$20,649,639	3,105,209	—	Shares	Sole	2026-02-17
No filing history on record for this holder in this stock.